SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-19-000081
Filing Date
2019-08-14
Accepted
2019-08-14 16:06:24
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare_10qx20190630.htm 10-Q 820330
2 EXHIBIT 31.1 exhibit311_20190630.htm EX-31.1 18326
3 EXHIBIT 31.2 exhibit312_20190630.htm EX-31.2 17655
4 EXHIBIT 32.1 exhibit321_20190630.htm EX-32.1 4941
5 EXHIBIT 32.2 exhibit322_20190630.htm EX-32.2 5028
12 darebioinlinefullcolorrgb.jpg GRAPHIC 130914
  Complete submission text file 0001401914-19-000081.txt   3980746

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dare-20190630.xml EX-101.INS 533098
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20190630.xsd EX-101.SCH 45188
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20190630_cal.xml EX-101.CAL 45217
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20190630_def.xml EX-101.DEF 174441
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20190630_lab.xml EX-101.LAB 504796
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20190630_pre.xml EX-101.PRE 276305
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 191026285
SIC: 2834 Pharmaceutical Preparations